The European Medicines Agency warns of a sharp rise in illegal medicines advertised and sold online.

Omissions

• The EMA warning specifically highlights illegal GLP-1 receptor agonists (weight-loss/diabetes medicines) rather than all illegal medicines generically, although it frames this as part of a broader growing threat of illegal medicines advertised and sold online.
• The claim does not specify a time period; the underlying EMA/HMA warning is dated 3 September 2025, which predates the session date and was therefore knowable by the MEP.

Sources

• PrimaryEuropean Medicines Agency (EMA) — Warning about sharp rise in illegal medicines sold in the EUTitle: 'Warning about sharp rise in illegal medicines sold in the EU'. Description: 'EMA and the Heads of Medicines Agencies (HMA) are warning the public about the growing threat of illegal medicines being advertised and sold...' and 'Illegal medicines marketed as GLP-1 receptor agonists for weight loss and diabetes pose serious risk to health.'
• SecondaryAGES (Austrian Agency for Health and Food Safety) — Sharp rise in illegal medicines in the EU'In recent months, the number of illegal drugs marketed for weight loss and the treatment of diabetes has risen sharply.'
• SecondaryLexisNexis — EMA and HMA warn of surge in illegal GLP-1 medicine sales across EU'The European Medicines Agency (EMA) and Heads of Medicines Agencies (HMA) have issued a joint warning. There has been a significant rise in the...'